image
Lexaria Bioscience Corp. LEXX
Healthcare - Biotechnology - NASDAQ - CA
Watchlist
$ 2.01
-5.19 %
$ 35.1 M
Market Cap
-4.9
P/E
BALANCE SHEET
3.08 M ASSETS
-60.63%
Growth Rates
1Year -60.63%
3Years 2.93%
5Years 4.87%
7Years 27.38%
10Years -3.02%
404 K LIABILITIES
100.51%
Growth Rates
1Year 100.51%
3Years 5.30%
5Years 56.06%
7Years -2.40%
10Years -13.74%
3.04 M EQUITY
-61.70%
Growth Rates
1Year -61.70%
3Years 6.43%
5Years 4.97%
7Years 41.65%
10Years 2.32%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lexaria Bioscience Corp.
image
Current Assets 2.2 M
Cash & Short-Term Investments 1.48 M
Receivables 175 K
Other Current Assets 547 K
Non-Current Assets 884 K
Long-Term Investments 0
PP&E 422 K
Other Non-Current Assets 463 K
Current Liabilities 268 K
Accounts Payable 225 K
Short-Term Debt 27.8 K
Other Current Liabilities 14.9 K
Non-Current Liabilities 136 K
Long-Term Debt 136 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Aug-2023 Aug-2022 Aug-2021 Aug-2020 Aug-2019 Aug-2018 Aug-2017 Aug-2016 Aug-2015 Oct-2013 Oct-2012 Oct-2011 Oct-2010 Oct-2009 Oct-2008 Oct-2007 Oct-2006 Oct-2005
ASSETS
Cash & Cash Equivalents 1.4 5.8 10.9 1.3 1.3 1.7 2.5 93.4 K 0.3 65.5 K 0.2 31.2 K 63 K 0.3 0.7 78.1 K 1.3 0.9
Short Term Investments 0.1 0.3 0.8 19.3 K 64.2 K 10.2 K 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.2 0.2 0.3 0.3 0.3 0.3 45.3 K 0.1 31.4 K 79.2 K 79.2 K 0.3 0.2 74.9 K 42.2 K 15.5 K 38.3 K 0
Inventory 0 38.4 K 29.6 K 0.1 0.1 87.2 K 67.2 K 0.1 0.2 0 0 0 0 6.19 K 0 0 17.6 K 0
Other Current Assets 0.5 0.6 0.3 0.2 68.9 K 0.2 0.1 0.2 0.2 0.4 1.51 K 1.48 K 2.15 K 2.34 K 6.19 K 6.19 K 35.2 K 1.73 K
Total Current Assets 2.2 7.0 12.4 1.9 1.8 2.3 2.8 0.5 0.7 0.1 0.5 0.3 0.1 0.4 0.7 0.1 1.3 0.9
PP&E 0.4 0.4 0.5 0.6 0.6 1.24 K 1.86 K 2.48 K 0 3.4 3.7 4.0 3.1 3.0 3.1 3.7 1.4 0.2
Intangible Assets 0.5 0.5 0.4 0.3 0.3 0.1 62.8 K 54 K 37 K 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 67.7 K 0 0 0 0 0 0 0 0
Other Long Term Assets 0 (0.9) (0.8) (0.9) (0.9) 0 0 0 0 67.7 K 0 33.1 K 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 3.1 7.8 13.3 2.8 2.7 2.4 2.9 0.6 0.7 3.6 4.2 4.3 3.3 3.3 3.8 3.8 2.7 1.1
LIABILITIES
Accounts Payable 0.2 25.8 K 59.9 K 45.1 K 31.5 K 14.4 K 32.6 K 90 K 33.1 K 93.6 K 0.1 67 K 0.3 0.1 0 2.7 K 19.4 K 1.69 K
Short Term Debt 27.8 K 85.2 K 47.3 K 36 K 0 0 0 0 0 1.3 1.3 1.6 0.8 0.9 0.3 0.3 50 K 2.0
Other Current Liabilities 0 51.7 K 45 K 96.7 K 89.4 K 29.3 K 42.7 K 0.3 22.1 K (0.5) 1.77 K 1.77 K 1.77 K 1.77 K 4.46 K 1.77 K 0.3 26.2 K
Total Current Liabilities 0.3 0.2 0.2 0.2 0.2 43.6 K 92.3 K 0.4 55.1 K 1.4 1.7 1.1 1.0 1.0 0.3 0.4 2.0 11.2 K
Long Term Debt 0.1 7.4 K 50 K 0.1 0 0 0 45 K 0 0 0 0 0.6 75 K 0 0.7 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 59.2 K 59.2 K 59.2 K 0 0 0 0 0 0
Total Liabilities 0.4 0.2 0.2 0.3 0.2 43.6 K 92.3 K 0.5 55.1 K 1.5 1.8 1.7 1.1 1.0 1.0 0.4 2.0 11.2 K
EQUITY
Common Stock 8.09 K 5.95 K 5.73 K 90 K 78.8 K 75.5 K 68 K 51.3 K 39.9 K 16.4 K 16.4 K 16.4 K 12.9 K 10.7 K 24.4 K 23.8 K 17.6 K 16.9 K
Retained Earnings (45.8) (39.1) (31.8) (27.8) (23.9) (19.8) (13.2) (11.3) (10.1) (5.1) (4.7) (4.5) (3.9) (3.4) (2.6) (1.6) (0.6) 75.7 K
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 14.2 K 0 0 0 35.2 K 0 0 0 0 0 0 0 0
Total Equity 2.7 7.6 13.1 2.5 2.5 2.4 2.8 87.8 K 0.7 2.1 2.4 2.7 2.2 2.3 2.8 3.4 0.7 1.1
Total Liabilities and Equity 3.1 7.8 13.3 2.8 2.7 2.4 2.9 0.6 0.7 3.6 4.2 4.3 3.3 3.3 3.8 3.8 2.7 1.1
SHARES OUTSTANDING
Common Shares Outstanding 6.6 5.9 4.4 2.8 2.6 2.4 2.0 1.5 1.3 25.7 0.6 0.5 0.5 0.3 0.2 0.2 0.2 55.1 K